CHELSI DAVIS: Open Payments
NPI 1225692098 · JASPER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,983 in 69 payments from 15 companies in 2025. Trend: 2023 $2,035 · 2024 $1,046 · 2025 $1,983
Food & beverage: $1,983
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $547 |
| Novartis Pharmaceuticals Corporation | 15 | $411 |
| Organon LLC | 7 | $193 |
| GENZYME CORPORATION | 4 | $186 |
| Lilly USA, LLC | 3 | $169 |
| UCB, Inc. | 2 | $87 |
| LEO Pharma Inc. | 3 | $85 |
| Galderma Laboratories, L.P. | 4 | $72 |
| Janssen Biotech, Inc. | 3 | $61 |
| Incyte Corporation | 2 | $51 |
Products named: SKYRIZI, RINVOQ, COSENTYX, VTAMA, EBGLYSS, Bimzelx, ADBRY, DUPIXENT.
Industry payments across AL — which companies pay providers there.
